This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to evaluate the feasibility, acceptability, clinical outcomes, affordability, and scalability of offering early antiretroviral treatment to all HIV-positive individuals in Swaziland's government-managed health system.

Provided treatments

  • Other: Early Access to ART for All

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02909218. The sponsor of the trial is Clinton Health Access Initiative Inc. and it is looking for 3485 volunteers for the current phase.
Official trial title:
MaxART: Early Access to ART for All in Swaziland